Go to the text
Certification for Cardiac Nursesa study reference for cardiac-vascular nurses

Practice topic · Draws on Domains I and II

Acute coronary syndrome care after MONA

MONA, the old mnemonic for morphine, oxygen, nitroglycerin and aspirin given to every patient with chest pain, still turns up in nursing notes and study cards. Current guidance treats each letter as a separate decision. This page goes through those four decisions, then follows the patient from the diagnosis to reperfusion, antiplatelet therapy and recovery.

Weight of each domain in the 125 scored items; filled squares mark where this topic draws from

  • IAssessment and Diagnosis (this topic draws on it)22 %
  • IIPlanning and Implementation (this topic draws on it)35 %
  • IIIEvaluation and Modification18 %
  • IVPatient and Community Education25 %

Try a question now16 more below

Item 1 / 17 · ACS

A patient has ST elevation in leads V1–V4. The cardiac-vascular nurse monitors most closely for which complication associated with this infarct location?

Choose an option; the reasons for all four open together.

  1. An LAD occlusion damages a large share of the left ventricle, so pump failure and cardiogenic shock are the main threats.

  2. The SA node is usually supplied by the right coronary artery, so this belongs to inferior MI.

  3. RV involvement goes with inferior MI from right coronary occlusion, not an anterior pattern.

  4. The posteromedial muscle depends on a single, usually right-sided artery, so it ruptures after inferior rather than anterior infarcts.

Show the key without choosing

Weight of each domain in the 125 scored items; filled squares mark where this topic draws from

  • IAssessment and Diagnosis (this topic draws on it)22 %
  • IIPlanning and Implementation (this topic draws on it)35 %
  • IIIEvaluation and Modification18 %
  • IVPatient and Community Education25 %

17 acute coronary syndrome questions

Four answer choices per item; pick the best one.

Tally: 0 right, 0 tried, 17 in this set

Item 2 / 17 · ACS

Five days after a large anterior MI, a patient suddenly becomes hypotensive with jugular venous distention and muffled heart sounds, then loses the pulse while the monitor still shows sinus rhythm. The most likely cause is:

  1. A septal tear brings a loud new holosystolic murmur with shock, not a silent, muffled heart.

  2. RV infarction causes hypotension and neck-vein distention early after an inferior MI, without muffled sounds or sudden pulselessness days later.

  3. Days 3–5 after a large MI, a free-wall tear fills the pericardium with blood: hypotension, distended neck veins and muffled sounds, then pulselessness while the monitor still shows a rhythm.

  4. This tear floods the lungs and adds a new apical systolic murmur; it does not muffle the heart sounds.

Show the key without choosing
Item 3 / 17 · ACS

A patient arrives 1 hour after the onset of chest pressure. The initial high-sensitivity troponin is below the 99th percentile. The cardiac-vascular nurse anticipates:

  1. Long waits belong to older assays; with high-sensitivity testing they only delay the answer.

  2. A single normal value this soon after onset cannot exclude MI.

  3. One hour after symptom onset the troponin may not have risen yet; a 0/1- or 0/2-hour protocol with a repeat sample is used before MI is excluded.

  4. CK-MB is no longer recommended once high-sensitivity troponin is available.

Show the key without choosing
Item 4 / 17 · ACS

The cardiac-vascular nurse is teaching a women's community group about heart attack symptoms. Which statement is accurate?

  1. This myth delays care; most women with MI do report chest discomfort.

  2. Any suspected heart attack warrants calling 911, whatever the symptom intensity.

  3. Arm or back pain can occur, but describing it as the usual replacement for chest pain is wrong.

  4. Chest pain or discomfort is the most common MI symptom in women too, though nausea, fatigue, breathlessness or jaw and back pain often come with it.

Show the key without choosing
Item 5 / 17 · ACS

The cardiac-vascular nurse teaches a patient on dual antiplatelet therapy after MI to report which finding immediately?

  1. Black, tarry stools signal upper GI bleeding, the most frequent serious bleed on dual antiplatelet therapy, and need prompt evaluation.

  2. Easy bruising is an expected nuisance on antiplatelet drugs and is no reason to stop them.

  3. Minor gum bleeding is common and is handled with a softer brush, not an urgent call.

  4. A brief nosebleed that stops with pressure is a minor effect; stopping DAPT over it risks stent thrombosis.

Show the key without choosing
Item 6 / 17 · ACS

A patient with stable angina asks why metoprolol succinate was prescribed. The cardiac-vascular nurse explains that beta-blockers relieve angina mainly by:

  1. Beta-blockers reduce contractility; a stronger beat would raise oxygen demand.

  2. A slower rate, lower pressure and less forceful contraction reduce how much oxygen the myocardium needs.

  3. That is aspirin's action; beta-blockers have no antiplatelet effect.

  4. Coronary dilation is how nitrates and calcium channel blockers work, not beta-blockers.

Show the key without choosing
Item 7 / 17 · ACS

A patient taking ranolazine for chronic stable angina has four new prescriptions. Which one should the cardiac-vascular nurse question?

  1. Ranolazine is broken down by CYP3A4; a strong inhibitor such as clarithromycin raises its level and prolongs the QT interval, so the combination is avoided.

  2. A beta-blocker is a standard partner for ranolazine in stable angina.

  3. Amlodipine is routinely paired with ranolazine for chronic angina.

  4. Low-dose aspirin has no meaningful interaction with ranolazine and is part of secondary prevention.

Show the key without choosing
Item 8 / 17 · ACS

A patient with stable angina predictably develops chest pain when walking up the hill to the mailbox. Which instruction from the cardiac-vascular nurse is appropriate?

  1. Using sublingual nitroglycerin a few minutes before a known trigger prevents the predictable episode and lets the patient stay active.

  2. Nitroglycerin is used at the onset of angina; letting pain run this long is how an MI goes untreated.

  3. Giving up activity leads to deconditioning, which lowers the angina threshold further.

  4. A faster pace makes the heart work harder and brings the angina on sooner.

Show the key without choosing
Item 9 / 17 · ACS

A 38-year-old woman who is 3 weeks postpartum and has no cardiovascular risk factors comes to the emergency department with chest pain and an elevated troponin. The cardiac-vascular nurse recognizes the most likely cause is:

  1. Plaque rupture is the usual MI mechanism in older patients with risk factors, which this patient does not have.

  2. Chest-wall inflammation does not raise troponin.

  3. A young woman weeks after delivery with no risk factors and a troponin rise fits spontaneous coronary artery dissection, a tear in the vessel wall rather than plaque.

  4. A raised troponin shows myocardial injury; labeling it anxiety is how these MIs are missed.

Show the key without choosing
Item 10 / 17 · ACS

When interviewing a 68-year-old patient with diabetes, which reported symptom does the cardiac-vascular nurse recognize as a possible anginal equivalent?

  1. Pain reproduced by pressing on the chest wall points to a musculoskeletal source.

  2. Burning feet at night fit peripheral neuropathy, a diabetes problem but not a cardiac one.

  3. Caffeine-related palpitations are common and are not a sign of myocardial ischemia.

  4. Diabetic neuropathy can blunt ischemic pain, so breathlessness with familiar exertion may be the only sign of ischemia.

Show the key without choosing
Item 11 / 17 · ACS

A patient has a left ventricular apical aneurysm after a large anterior MI. The cardiac-vascular nurse monitors most closely for:

  1. Heart block is an early conduction problem of the infarct itself, not a consequence of a healed aneurysm.

  2. Blood stagnates in the akinetic aneurysm sac, so clot forms against the wall and can travel to the brain; new neurologic signs are reported at once.

  3. A true aneurysm has a thick scarred wall and rarely ruptures; rupture is the risk of a false aneurysm.

  4. An apical aneurysm does not involve the aortic valve.

Show the key without choosing
Item 12 / 17 · ACS

A patient being treated for a bleeding duodenal ulcer has a hemoglobin of 6.5 g/dL, HR 128/min, new ST depression, and a rising troponin. The cardiac-vascular nurse anticipates that the priority treatment is:

  1. Urgent angiography is for a thrombotic (type 1) MI; here the problem is oxygen delivery, not a blocked artery.

  2. A potent antiplatelet drug treats plaque rupture, not a bleed-induced oxygen shortfall, and would worsen the hemorrhage.

  3. Anticoagulating a patient who is actively bleeding from the gut adds to the blood loss driving the ischemia.

  4. Severe anemia and a fast rate leave the heart muscle short of oxygen, a type 2 MI; restoring hemoglobin treats the cause.

Show the key without choosing
Item 13 / 17 · ACS

A patient with angina is prescribed nitroglycerin lingual pump spray. Which technique does the cardiac-vascular nurse teach?

  1. Inhaling sends the drug toward the lungs instead of the mouth lining, which is the inhaler habit again.

  2. The spray is absorbed through the mouth lining; it is directed onto or under the tongue and the mouth is closed without breathing it in.

  3. Rinsing or swallowing right away washes the dose off the tongue before it is absorbed.

  4. The label for the pump spray says not to shake it; patients often carry over the habit from asthma inhalers.

Show the key without choosing
Item 14 / 17 · ACS

During an admission interview, a patient with exertional symptoms says, "I don't have chest pain." Which follow-up question should the cardiac-vascular nurse ask?

  1. Many patients describe ischemia as pressure, tightness or heaviness and answer no when asked only about pain, so the nurse asks in their terms.

  2. Steering toward a stomach cause early can lead both patient and nurse to dismiss ischemic discomfort.

  3. Sharp, breath-related pain points away from ischemia, so this question would not uncover a pressure-type symptom.

  4. The patient has just denied pain; a pain score skips the step of finding out what they do feel.

Show the key without choosing
Item 15 / 17 · ACS

A patient's chest pain eased 3 minutes after sublingual nitroglycerin. The patient says, "So it was my heart." The cardiac-vascular nurse explains that relief after nitroglycerin:

  1. Pain can ease while an MI continues; relief does not exclude infarction.

  2. Treating the response as proof is the classic error that misses esophageal and other causes.

  3. Esophageal spasm and other causes can ease after nitroglycerin, so relief is not used to decide that chest pain is from the heart.

  4. Nitroglycerin response says nothing about the degree of coronary narrowing.

Show the key without choosing
Item 16 / 17 · ACS

A nurse charts "atypical chest pain" for a 72-year-old woman with jaw discomfort and fatigue on exertion. Current chest pain guidance discourages that term because:

  1. Current chest pain guidance asks for "cardiac, possibly cardiac or noncardiac" instead, because "atypical" is easily taken to mean harmless.

  2. Timing of laboratory results is not why the term is discouraged.

  3. The term has no link to the ECG; its problem is how it is interpreted.

  4. Vasospastic angina is a diagnosis, not what "atypical" was meant to label.

Show the key without choosing
Item 17 / 17 · ACS

A patient admitted with suspected NSTE-ACS has had two nondiagnostic ECGs. While on the unit, the patient reports new chest pressure. Which action best helps the diagnosis?

  1. Troponin is checked as ordered, but delaying the ECG loses the chance to capture the changes now.

  2. Ischemic changes can come and go with symptoms, so a tracing during the episode can show what earlier tracings missed.

  3. One monitor lead shows the rhythm but cannot show the regional ST changes a 12-lead captures.

  4. After the episode passes, transient ST changes may already be gone.

Show the key without choosing

–/17

Your tally for this page

Kept in this tab alone: closing or refreshing the tab wipes it.

The set after this: EKG rhythm interpretationThe CV-BC outline and every topic

MONA taken apart, letter by letter

The 2025 ACC/AHA/ACEP/NAEMSP/SCAI acute coronary syndromes guideline (2025) is the current US reference. Read against it and the trials behind it, the four letters no longer travel together.

  • Morphine. Opioids are kept for ischemic pain that persists after other measures, not given by reflex. In the IMPRESSION trial (Eur Heart J, 2016), IV morphine delayed and weakened the effect of oral ticagrelor in patients with myocardial infarction, which matters in the hours when platelet inhibition is the treatment.
  • Oxygen. The DETO2X-AMI trial (NEJM, 2017) gave oxygen or room air to 6,629 patients with suspected MI and normal saturation and found no difference in death at one year. Supplemental oxygen is now for hypoxemia, with an SpO2 below 90% as the usual trigger.
  • Nitroglycerin. It relieves ischemic pain and helps with congestion and high blood pressure, but in ISIS-4 (Lancet, 1995), with 58,050 patients, oral nitrate did not lower mortality. It treats symptoms, not the infarct.
  • Aspirin. The one letter that survives intact: a chewed, non-enteric-coated loading dose as early as possible, then low-dose aspirin every day. Doses follow the order.

One syndrome, three diagnoses

Acute coronary syndrome covers three diagnoses that share a cause, a coronary plaque that ruptures or erodes and triggers a clot, but split on two tests.

  • STEMI: ST elevation that meets the ECG criteria, usually from a complete occlusion. It is diagnosed on the ECG, and reperfusion starts without waiting for a lab value.
  • NSTEMI: no ST elevation, but a troponin rise that meets the definition of infarction.
  • Unstable angina: ischemic symptoms with no troponin rise.

The last two are grouped as non-ST-elevation ACS (NSTE-ACS) and managed by risk: some go to angiography within hours, others within 24 hours or before discharge, and some low-risk patients have noninvasive testing first. The definitions come from the Fourth Universal Definition of Myocardial Infarction (2018), which requires a rise or fall of cardiac troponin with at least one value above the 99th percentile upper reference limit, together with evidence of ischemia.

High-sensitivity troponin: injury or infarction

High-sensitivity assays detect troponin at much lower concentrations than older tests, so many more patients have a measurable level. The 2018 universal definition sets the upper reference limit at the 99th percentile of a healthy population for the specific assay, and recommends separate limits for women and men.

A value above that limit means myocardial injury. It becomes an infarction only with evidence of ischemia: symptoms, ECG changes or imaging. Sepsis, kidney disease, myocarditis, pulmonary embolism and heart failure all raise troponin without a blocked coronary artery, which is why the definition asks for both.

Reperfusion clocks

For STEMI the clock runs from first medical contact. The goal for primary PCI (percutaneous coronary intervention) is 90 minutes or less from first contact to the device, or 120 minutes or less when the patient must be transferred to a PCI center. Where PCI cannot happen in that window and symptom onset was within the last 12 hours, the 2025 guideline recommends fibrinolytic therapy instead, followed by transfer to a PCI center.

Units track these times as quality measures, which the CV-BC outline gives next to ACC/AHA guidelines as its example for evidence-based practice (II.A.1). Access sites, sheaths and the hours after the procedure belong to cardiac catheterization and PCI.

Antiplatelet therapy after the event

Dual antiplatelet therapy pairs aspirin with a P2Y12 inhibitor: clopidogrel, prasugrel or ticagrelor. It lowers the risk of another infarct and raises the risk of bleeding, so the 2025 guideline sets the drug and the length of therapy by weighing the two for each patient, with separate strategies for those at high bleeding risk. Teaching after a stent is part of cardiac catheterization and PCI.

In the acute phase a parenteral anticoagulant, usually heparin, runs alongside; its monitoring is on anticoagulation.

When the pump fails: cardiogenic shock in short

The SCAI SHOCK stage classification update (2022) grades it from A (at risk) through B (beginning), C (classic), D (deteriorating) to E (extremis), so that everyone caring for a patient in shock describes the same patient the same way.

Care at stages C to E is critical-care work: vasoactive drugs, mechanical support and invasive monitoring. In the DanGer Shock trial (NEJM, 2024), a microaxial flow pump lowered death at 180 days in STEMI with cardiogenic shock but brought more bleeding and limb ischemia. On a cardiac-vascular unit the task is earlier: noticing the slide from A to B and calling it in.

From the infarct to chronic coronary disease

Once the patient leaves the acute phase, care moves to the 2023 AHA/ACC multisociety chronic coronary disease guideline (2023), which treats coronary disease as a lifelong condition: antiplatelet therapy, lipid lowering, blood pressure, diabetes, weight, activity and smoking, revisited at every visit.

Two other topics pick up the threads: cardiac rehabilitation for the referral and the exercise program, and heart failure for long-term care of the ventricle.

Phone app links

App StoreGoogle Play

Coronary care questions, ready on your phone

The 2025 guideline

Which documents did the 2025 ACS guideline replace?

It replaced the 2013 ACCF/AHA guideline for STEMI and the 2014 AHA/ACC guideline for NSTE-ACS, so both presentations are now covered in one document, published in February 2025 by the ACC, the AHA and three emergency and interventional societies.

The set after this

EKG rhythm interpretation

Draws on Domains I and II

Take the next set

The papers behind this page

10 documents, listed by tag
  1. TCOCV-BC Test Content Outline, ANCC, effective Dec. 5, 2024 (PDF reissued Aug. 7, 2026 with 2026 branding), pp. 1–3source site nursingworld.org · fetched Nov 20, 2026
  2. RDSANCC role delineation study executive summary for Cardiac-Vascular Nursing, August 2024 (PDF), pp. 1–3source site nursingworld.org · fetched Nov 20, 2026
  3. S2025 ACC/AHA/ACEP/NAEMSP/SCAI acute coronary syndromes guideline (2025)source site pubmed.ncbi.nlm.nih.gov
  4. S2IMPRESSION trial (Eur Heart J, 2016)source site pubmed.ncbi.nlm.nih.gov
  5. S3DETO2X-AMI trial (NEJM, 2017)source site pubmed.ncbi.nlm.nih.gov
  6. S4ISIS-4 (Lancet, 1995)source site pubmed.ncbi.nlm.nih.gov
  7. S5Fourth Universal Definition of Myocardial Infarction (2018)source site pubmed.ncbi.nlm.nih.gov
  8. S6SCAI SHOCK stage classification update (2022)source site pubmed.ncbi.nlm.nih.gov
  9. S7DanGer Shock trial (NEJM, 2024)source site pubmed.ncbi.nlm.nih.gov
  10. S82023 AHA/ACC multisociety chronic coronary disease guideline (2023)source site pubmed.ncbi.nlm.nih.gov